What is the pregnancy category for Ramipril?

Ramipril, an ACE inhibitor used primarily for managing hypertension and heart failure, falls under pregnancy category D. This category signifies that there is positive evidence of risk to the fetus based on human data, particularly when medications are administered during the second and third trimesters. Ramipril can lead to adverse effects such as fetal renal impairment, oligohydramnios, and even death, which make careful consideration of its use in pregnant women crucial.

It’s important to always evaluate the risks against the benefits when considering medications in pregnancy, but the classification of Ramipril as category D underscores its recognized potential dangers to fetal development. This classification guides healthcare professionals to recommend alternative therapies for hypertensive pregnant patients whenever possible.